Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation

1 February 2000

journal article
research article
Published by Springer Nature in Bone Marrow Transplantation

Vol. 25 (3) , 237-241
https://doi.org/10.1038/sj.bmt.1702126

Abstract

IL-10 is a potent immunosuppressant which inhibits allo-antigen-specific T cell responses. In addition, IL-10 is a strong endogenous anti-inflammatory cytokine. To investigate the role of IL-10 in the induction of acute GVHD following allogeneic bone marrow transplantation (BMT) we performed a prospective study on spontaneous IL-10 production by peripheral blood mononuclear cells (PBMNC) in 84 patients admitted for allogeneic BMT. High spontaneous IL-10 production by PBMNC at the time of admission and prior to any preparative treatment correlated with a subsequent low incidence of GVHD and transplant-related mortality (8%), as compared to patients with low or intermediate IL-10 production (50%, P < 0.01). Our data demonstrate the prognostic significance of increased IL-10 production in BMT patients and suggest a major role of IL-10 in maintaining immunobalance in the setting of allogeneic BMT. Bone Marrow Transplantation (2000) 25, 237–241.

Keywords

This publication has 20 references indexed in Scilit:

INFLUENCE OF BACTERIAL ENDOTOXIN ON RADIATION-INDUCED ACTIVATION OF HUMAN ENDOTHELIAL CELLS IN VITRO AND IN VIVO
Transplantation, 1997
High interleukin-10 serum levels are associated with fatal outcome in patients after bone marrow transplantation
Bone Marrow Transplantation, 1997
INFLUENCE OF BACTERIAL ENDOTOXIN ON RADIATION-INDUCED ACTIVATION OF HUMAN ENDOTHELIAL CELLS IN VITRO AND IN VIVO
Transplantation, 1996
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
The Journal of Experimental Medicine, 1996
Cellular immune responses to autologous chronic myelogenous leukaemia cells in vitro
Cancer Immunology, Immunotherapy, 1996
Lipopolysaccharide‐induced interleukin‐10 in mice: role of endogenous tumor necrosis factor‐α
European Journal of Immunology, 1995
Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes
European Journal of Immunology, 1994
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
The Journal of Experimental Medicine, 1994
Interleukin 10 protects mice from lethal endotoxemia.
The Journal of Experimental Medicine, 1993
Low Incidence of Transplant-Related Complications in Patients with Chronic Release of Tumor Necrosis Factor-Alpha before Admission to Bone Marrow Transplantation: A Clinical Correlate of Cytokine Desensitization?
Pathobiology, 1991